Table 2.
Glomerular C4d staining in C3 glomerulopathy
| Patient | Pathology Diagnosis | C4d | C3 | C1q | Ig |
|---|---|---|---|---|---|
| 1 | C3 GN | 0 | 3 | 0 | 0 |
| 2 | C3 GN/MPGN I | Trace–1 | 3 | 0 | IgG 1+ |
| 3 | C3 GN/MPGN I | 1 | 3 | 2 | IgG 1+ |
| 4 | DDD | 0 | 3 | 0 | 0 |
| 5 | C3 GN | 0 | 2–3 | 0 | 0 |
| 6 | C3 GN/MPGN I | 0 | 3 | 0 | 0 |
| 7 | C3 GN | 0 | 3 | 0 | 0 |
| 8 | C3 GN/MPGN type III | 0 | 3 | 0 | 0 |
| 9 | C3 GN | 0 | 3 | 0 | 0 |
| 10 | C3 GN, recurrent | 0 | 3 | 0 | 0 |
| 11 | C3 GN | 0 | 3 | 0 | 0 |
| 12 | C3 GN | 0 | 3 | 0 | 0 |
| 13 | C3 GN | 0 | 2 | 0 | 0 |
| 14 | C3 GN | 0 | 3 | 0 | 0 |
| 15 | C3 GN | 0 | 3 | 0 | IgG 1+ |
| 17 | C3 GN | Trace | 3 | 0 | 0 |
| 18 | C3 GN | 0 | 2–3 | 0 | 0 |
| 19 | C3 GN | 0 | 3 | 0 | 0 |
| 20 | C3 GN | 0 | 3 | 0 | 0 |
| 21 | C3 GN | 0 | 2 | 0 | 0 |
| 22 | C3 GN | Trace | 3 | 0 | 0 |
| 23 | C3 GN | 0 | 3 | 0 | 0 |
| 24 | C3 GN | 1 | 3 | 0 | 0 |
| 25 | C3 GN | 1+ | 3 | 0 | IgG 1+ |
| 26 | DDD, recurrent | 0 | 3 | 0 | 0 |
| 27 | DDD | 0 | 3 | 0 | 0 |
| 28 | DDD | 0 | 3 | 0 | 0 |
| 29 | DDD | 0 | 3 | 0 | 0 |
| 30 | DDD | 0 | 3 | 0 | 0 |